PR-Inside.com: 2024-04-28 20:34:27
NEW YORK, NY / ACCESSWIRE / April 28, 2024 / If you suffered a loss on your Ventyx Biosciences, Inc. (NASDAQ:VTYX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
https://zlk.com/pslra-1/ventyx-biosciences-inc-lawsuit-submission-form?prid=77407&wire=1
or contact Joseph E. Levi, Esq. via email at jlevi@
levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: A class action securities lawsuit was filed against Ventyx Biosciences, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between October 21, 2021 and November 6, 2023.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) VTX958, the Company's lead clinical product candidate, was less effective in treating psoriasis than defendants had led investors to believe; (ii) as a result, VTX958's clinical and/or commercial prospects were overstated; (iii) accordingly, the Company had misrepresented its ability to develop and commercialize effective product candidates; (iv) Ventyx's business prospects following the initial public offering were thus inflated; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Ventyx stock during the relevant time frame - even if you still hold your shares - go to
https://zlk.com/pslra-1/ventyx-biosciences-inc-lawsuit-submission-form?prid=77407&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLPJoseph E. Levi,
Esq.Ed Korsinsky,
Esq.33 Whitehall Street, 17th FloorNew York, NY 10004 jlevi@
levikorsinsky.com Tel: (212) 363-7500Fax: (212) 363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP
